COVID Antibody Testing using rapid kits: Limitations

In our last blog, we covered the importance and utility of Rapid Antibody Testing, especially in COVID-19 hotspots. However, it is important to understand the limitations of the rapid antibody test and that it cannot be used as a means for diagnosing COVID-19. It only analyses past infection\exposure to COVID-19. BUT it doesn’t replace the confirmatory diagnosis of COVID-19 provided by Real Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) test, mandated by WHO. Click here to read the CDC information on rapid antibody tests.

Rapid covid antibody test
COVID Rapid antibody test kit example

Let’s have a look at the limitations and challenges of Rapid Antibody Tests

  • Body’s antibody response to COVID-19 is relatively slower than usually expected. While supporting data is limited at this point, it has been observed that the initial IgM antibody response doesn’t peak until 9 days after initial infection and the IgG antibody response doesn’t peak until day 11, whereas most viruses take 5 days to produce initial immune response.
  • Rapid test can ensure the immunity of people but cannot provide the information that would confirm that they are no longer carriers of the virus. For that purpose, RT-PCR plays an important role.
  • It may give false negative results – if done in the window period before the antibody appears in the system [antibody takes 8-14 days to develop following natural infection]
  • Technical challenges in making antigens: Difficult to make the protein in laboratories using cell cultures which forms the viral coat, essential to trigger the immune response to produce antibodies for inclusion in immunoassays. There are questions which antigens [proteins] are the best to produce antibodies
    • Nucleocapsid protein: the most abundant viral protein, which means it’s easy to detect, but less specific
    • Spike protein: more specific, more divergent but which part of it to be used is less obvious
  • False positive results: due to cross reactivity to other coronavirus infections; amino acids of the spike proteins of SARS and the COVID-19 virus, there’s a 75% identity and overall figure for common cold-causing coronaviruses is probably about 50–60%.

Related Blogs

New Read
Know about Long Covid-19

Defining long COVID has been a challenge. The current definition includes four criteria ICU admission leading to long-term disability or alteration in lifestyle Damage to an end-or...

New Read
Is it COVID or the Flu or some other infection?

This monsoon, we observe that patients with Fever, Sore throat, and a persistent cough are increasing. The doctors suspect it to be COVID-19, but the Covid RT-PCR reports are nega...

By Dr. Pooja Gumaste Jul 22, 2021
New Read
D-Dimer In COVID-19: 11 Important Questions

People have asked us about D-Dimer testing in COVID. Some of the commonly asked questions are: Why do COVID-19 patients need the D-Dimer test? Does COVID-19 Pneumonia cause a raise...

By Dr. Pooja Gumaste Jul 15, 2021